Metabolic Syndrome among Polycystic Ovarian Syndrome in Malaysia
The prevalence of Metabolic Syndrome among Polycystic Ovarian Syndrome patients and its associated factors in Malaysia
Versandkostenfrei!
Versandfertig in 6-10 Tagen
32,99 €
inkl. MwSt.
PAYBACK Punkte
16 °P sammeln!
Polycystic Ovarian Syndrome (PCOS) is an important health issue affecting reproductive women today. Apart from being the most common endocrinopathy, it is also one of the leading causes of infertility. Whilst, Metabolic Syndrome (MS) is a syndrome comprises of multiple risk factors that predispose someone to the risk of atherosclerotic cardiovascular disease and type 2 diabetes. Worldwide, there are many studies looking into the prevalence of Metabolic Syndrome (MS) either in general or in specific population. This study specifically looked on the prevalence of MS among Polycystic Ovarian Synd...
Polycystic Ovarian Syndrome (PCOS) is an important health issue affecting reproductive women today. Apart from being the most common endocrinopathy, it is also one of the leading causes of infertility. Whilst, Metabolic Syndrome (MS) is a syndrome comprises of multiple risk factors that predispose someone to the risk of atherosclerotic cardiovascular disease and type 2 diabetes. Worldwide, there are many studies looking into the prevalence of Metabolic Syndrome (MS) either in general or in specific population. This study specifically looked on the prevalence of MS among Polycystic Ovarian Syndrome (PCOS). It also looked into the associated factors which determine the MS prevalence among PCOS population. It is a cross sectional study, involving 106 PCOS patients attending Gynaecology clinic. The diagnostic criteria used for MS was IDF 2005. The prevalence of MS among PCOS patients studied was 43.4%. Age and family history of Diabetes Mellitus are the two important determinant factors for MS.
Andere Kunden interessierten sich für
